PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California. Show more

Location: 150 Baytech Drive, San Jose, CA, 95134, United States | Website: https://www.procept-biorobotics.com | Industry: Medical Devices | Sector: Healthcare


Market Cap

3.134B

52 Wk Range

$47.04 - $103.81

Previous Close

$59.21

Open

$58.40

Volume

548,064

Day Range

$56.37 - $58.81

Enterprise Value

2.953B

Cash

316.2M

Avg Qtr Burn

-20.98M

Insider Ownership

4.22%

Institutional Own.

93.06%

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date